Evaluating Efficacy of Digital Health Technology in the Treatment of Congestive Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 182 participants.

Also called NCT04394754

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 182 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04394754
Other papers using this trial's data
  • Impact of Digital Health Technology on Quality of Life in Patients With Heart Failure JACC. Heart failure, 2024-02 DOI, PubMed 37943227

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04394754. Randomized; single masking; primary purpose supportive care. Start 2020-09-21 (actual); primary completion 2021-09-20 (actual). Results posted on 2022-12-23.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluating Efficacy of Digital Health Technology in the Treatment of Congestive Heart Failure
Condition
Congestive Heart Failure
Intervention (Device)
BodyPort
Intervention (Other)
Noom
Intervention (Other)
Conversa
Lead sponsor
Yale University (class: other)
Collaborator
Boehringer Ingelheim (class: industry)
Collaborator
ZS (class: industry)

Record details

Record id
cardio:ct-nct04394754
Content hash
70df974546f9d64b4cba61d5e3d574739999b7fce8a239ce43b08f5b1b692202